Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIRAL intravenous lidocaine pharmacokinetic study in bariatric surgery
2015-001145-93Phase 3Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lidocaine in obesity, sponsored by Hospices Civils de Lyon. Primary endpoints: Safety of modified-weight-based intravenous lidocaine administration, Peak lidocaine plasma concentration and 4 more. Started Jun 2015; status: active.
02
Drugs
lidocaine
03
Conditions
obesity
Beyond the preview
Go deeper on 2015-001145-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001145-93.